Literature DB >> 5551249

New concepts in treatment of malignant tertian malaria with cerebral involvement.

H Smitskamp, F H Wolthuis.   

Abstract

Of 140 patients with malignant tertian malaria seen during 1956 to 1967 10 died. Death was caused by cerebral malaria in all cases. Since 1968 more intensified treatment has resulted in the complete recovery of three patients and the partial recovery of one, all of whom had been in a cerebral malaria coma for various periods of time before admission and in whom a fatal outcome was expected. In these cases a polypragmatic therapeutic approach using intravenous low molecular weight dextran, besides the usual quinine and fluids, corticosteroids, heparin and urea, separately or combined, was adopted.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5551249      PMCID: PMC1795472          DOI: 10.1136/bmj.1.5751.714

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  5 in total

1.  KNOWLESI MALARIA IN MONKEYS II: A FIRST STEP IN THE SEPARATION OF THE MECHANICAL PATHOLOGIC CIRCULATORY FACTORS OF ONE SLUDGE DISEASE FROM POSSIBLE SPECIFIC TOXIC FACTORS OF THAT DISEASE.

Authors:  M H KNISELY; W K STRATMAN-THOMAS; T S ELIOT; E H BLOCH
Journal:  Angiology       Date:  1964-09       Impact factor: 3.619

2.  125-I-labelled fibrinogen in cerebral malaria.

Authors:  K Devakul; T Harinasuta; H A Reid
Journal:  Lancet       Date:  1966-10-22       Impact factor: 79.321

3.  Fatal pulmonary edema as a complication of acute falciparum malaria.

Authors:  J G Deaton
Journal:  Am J Trop Med Hyg       Date:  1970-03       Impact factor: 2.345

4.  [Introduction of diseases by travellers and immigrants].

Authors:  W Mohr
Journal:  Munch Med Wochenschr       Date:  1969-07-11

5.  Imported malaria in the United Kingdom.

Authors:  P G Shute; M Maryon
Journal:  Br Med J       Date:  1969-06-28
  5 in total
  16 in total

1.  Antibodies to a histidine-rich protein (PfHRP1) disrupt spontaneously formed Plasmodium falciparum erythrocyte rosettes.

Authors:  J Carlson; G Holmquist; D W Taylor; P Perlmann; M Wahlgren
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

2.  Low anticoagulant heparin disrupts Plasmodium falciparum rosettes in fresh clinical isolates.

Authors:  Anna M Leitgeb; Karin Blomqvist; Fidelis Cho-Ngwa; Moses Samje; Peter Nde; Vincent Titanji; Mats Wahlgren
Journal:  Am J Trop Med Hyg       Date:  2011-03       Impact factor: 2.345

Review 3.  Combating malaria with nanotechnology-based targeted and combinatorial drug delivery strategies.

Authors:  Miloni Thakkar; Brijesh S
Journal:  Drug Deliv Transl Res       Date:  2016-08       Impact factor: 4.617

4.  Exotic disease.

Authors: 
Journal:  Br Med J       Date:  1971-07-03

5.  Malaria risk to travellers.

Authors: 
Journal:  Br Med J       Date:  1973-03-24

6.  Fucosylated chondroitin sulfate inhibits Plasmodium falciparum cytoadhesion and merozoite invasion.

Authors:  Marcele F Bastos; Letusa Albrecht; Eliene O Kozlowski; Stefanie C P Lopes; Yara C Blanco; Bianca C Carlos; Catarina Castiñeiras; Cristina P Vicente; Claudio C Werneck; Gerhard Wunderlich; Marcelo U Ferreira; Claudio R F Marinho; Paulo A S Mourão; Mauro S G Pavão; Fabio T M Costa
Journal:  Antimicrob Agents Chemother       Date:  2014-01-06       Impact factor: 5.191

7.  Haemostatic defect in non-immune patients with falciparum malaria: no evidence of diffuse intravascular coagulation.

Authors:  J Vreeken; T M Cremer-Goote
Journal:  Br Med J       Date:  1978-08-19

Review 8.  The treatment of malaria.

Authors:  A P Hall
Journal:  Br Med J       Date:  1976-02-07

9.  Growth-inhibitory effect of heparin on Babesia parasites.

Authors:  Sabine Bork; Naoaki Yokoyama; Yuzuru Ikehara; Sanjay Kumar; Chihiro Sugimoto; Ikuo Igarashi
Journal:  Antimicrob Agents Chemother       Date:  2004-01       Impact factor: 5.191

10.  Malaria in the United Kingdom.

Authors:  L J Bruce-Chwatt; B A Southgate; C C Draper
Journal:  Br Med J       Date:  1974-06-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.